Cervicogenic Headache vs. Migraine: Medication and Documentation Guide
Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 29, 2026 | 7 min read
Cervicogenic headache and migraine require different medications, different specialists, and different documentation strategies. This guide explains the diagnostic distinctions, treatment protocols, and how the pharmacy record differentiates these conditions for personal injury cases.
Cervicogenic headache is a secondary headache disorder caused by dysfunction in the cervical spine structures — facet joints, discs, ligaments, or muscles — while migraine is a primary neurological disorder involving cortical spreading depression and trigeminal activation. The two conditions require entirely different medication protocols, and the pharmacy record distinguishes them with clinical precision that imaging studies and subjective complaints cannot match.
- Cervicogenic headache originates from cervical spine pathology and responds to muscle relaxants, nerve blocks, and anti-inflammatory agents — not triptans or CGRP medications (Sjaastad et al., Headache, 1998)
- Migraine is a neurological disorder treated with migraine-specific agents: triptans for acute attacks and CGRP antagonists for prevention (FDA-approved CGRP agents: Qulipta, Nurtec ODT, Aimovig, Emgality, Ajovy, Vyepti)
- LienScripts covers medications for both cervicogenic headache and migraine on pharmacy lien, and each case receives a MERIT (Medication Evaluation & Rationale for Injury Treatment) report that identifies which headache type the prescribing pattern supports
- According to James Wong, PharmD, founder of LienScripts, "The medication record itself is diagnostic — a patient on tizanidine and trigger point injections has a cervicogenic pattern, while a patient on sumatriptan and Qulipta has a migraine pattern"
- Many post-accident patients develop both conditions simultaneously, and the dual medication record documents two distinct injury mechanisms
Why the Distinction Matters in PI Cases
Defense counsel frequently conflate cervicogenic headache with migraine, arguing that "headache" is a single, minor complaint. In reality, these are separate diagnoses with separate ICD-10 codes (G44.86 for cervicogenic headache, G43.x for migraine), separate treatment pathways, and separate implications for injury severity.
A patient diagnosed with both cervicogenic headache and post-traumatic migraine has two documented injury conditions — cervical spine pathology and neurological dysfunction — arising from the same accident. This dual diagnosis supports claims for both orthopedic/musculoskeletal and neurological damages.
[!KEY] Cervicogenic headache and migraine are separate diagnoses with separate treatment protocols. A patient prescribed both muscle relaxants (cervicogenic) and CGRP agents (migraine) has pharmacy documentation of two distinct injury mechanisms from the same accident — strengthening the case for comprehensive damages.
Cervicogenic Headache: The Cervical Spine Pattern
Diagnostic Features
Cervicogenic headache typically presents as:
- Unilateral pain starting at the neck and radiating to the forehead or temple
- Pain provoked by neck movement or sustained posture
- Reduced cervical range of motion
- Associated neck tenderness on examination
The International Headache Society (ICHD-3) diagnostic criteria require evidence of cervical spine causation, which can be established through imaging, clinical examination, or — critically — response to diagnostic cervical nerve blocks.
Medication Protocol
The cervicogenic headache medication record shows a musculoskeletal pattern:
- Muscle relaxants — tizanidine, cyclobenzaprine, methocarbamol, or baclofen for cervical muscle spasm
- NSAIDs — meloxicam, diclofenac, or celecoxib for cervical inflammation
- Neuropathic agents — gabapentin or pregabalin if cervical nerve irritation is present
- Trigger point injections — lidocaine or corticosteroid injections into cervical trigger points (procedural, not pharmacy)
- Cervical epidural steroids — for disc-related cervicogenic headache (procedural)
As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "When I see cyclobenzaprine, meloxicam, and gabapentin in the pharmacy record — with no triptans or CGRP agents — that pattern is classic cervicogenic headache. The drugs tell the story of a spine injury causing headaches."
[!TIP] If your client is prescribed muscle relaxants and NSAIDs for headache rather than migraine-specific medications, the pharmacy record supports a cervicogenic headache diagnosis even if the medical records are ambiguous. The prescribing pattern is inherently diagnostic.
Migraine: The Neurological Pattern
Diagnostic Features
Post-traumatic migraine typically presents as:
- Pulsating or throbbing pain, often unilateral
- Associated nausea, vomiting, photophobia, or phonophobia
- Aura in some patients (visual disturbances, sensory changes)
- Not primarily provoked by neck movement
Medication Protocol
The migraine medication record shows a neurological pattern:
- Triptans — sumatriptan, rizatriptan, eletriptan for acute attacks (serotonin 5-HT1B/1D agonists — migraine-specific)
- CGRP antagonists — Qulipta, Nurtec ODT for prevention; Aimovig, Emgality, Ajovy, Vyepti as injectable options
- Anti-nausea agents — ondansetron, promethazine for migraine-associated nausea
- Older preventives — topiramate, amitriptyline, propranolol, venlafaxine for daily prevention
The critical differentiator: triptans and CGRP agents are prescribed exclusively for migraine. Their presence in the pharmacy record is diagnostic.
The Dual Diagnosis: Both Conditions Together
Post-accident patients frequently develop both cervicogenic headache (from whiplash or cervical spine injury) and post-traumatic migraine (from head impact or concussive forces). The pharmacy record in a dual-diagnosis patient shows medications from both patterns:
- Muscle relaxant (cervicogenic) + triptan (migraine)
- NSAID (cervicogenic) + CGRP agent (migraine)
- Gabapentin (overlapping — treats both cervical neuropathy and migraine prevention)
- Anti-nausea medication (migraine-associated)
[!KEY] A dual medication pattern — muscle relaxants alongside triptans or CGRP agents — documents two separate injury mechanisms requiring two separate treatment strategies. This dual-pattern pharmacy record supports claims for both musculoskeletal and neurological damages, effectively doubling the documented injury scope.
Diagnostic Medications: Pharmacy Records as Proof
Certain medications serve a diagnostic function:
Triptan Response Test
If a headache responds to a triptan, it is migraine — triptans do not treat cervicogenic headache. The pharmacy record showing triptan prescriptions with documented efficacy is diagnostic confirmation of migraine.
Muscle Relaxant Response
If headaches improve with muscle relaxants, the cervical musculoskeletal component is confirmed. Muscle relaxants do not treat migraine.
Nerve Block Response
Cervicogenic headache is definitively diagnosed when pain resolves after a diagnostic cervical nerve block (C2-C3 medial branch or greater occipital nerve block). While the block itself is procedural, the subsequent medication changes documented in the pharmacy record corroborate the diagnosis.
Documentation Strategy for Attorneys
- Separate the medication classes — organize the pharmacy record into cervicogenic medications and migraine medications to show the dual injury pattern
- Request the MERIT report — LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report that categorizes medications by therapeutic class, making the dual-diagnosis pattern immediately visible
- Identify diagnostic medications — triptans and CGRP agents definitively prove migraine; muscle relaxants and cervical-specific agents support cervicogenic headache
- Timeline the onset — cervicogenic headache typically begins immediately after injury, while post-traumatic migraine may develop over days to weeks
[!TIP] In demand letters, present the two headache types separately with their respective medication protocols. This prevents defense counsel from collapsing two diagnoses into a single "headache" complaint and forces separate valuation of each injury.
Common Defense Arguments and Rebuttals
"It's Just a Headache"
The pharmacy record proves otherwise. Two distinct medication classes treating two distinct pathologies — cervical spine dysfunction and neurological migraine — document two separate conditions, not "a headache."
"The Cervicogenic Headache Is Really Just Tension Headache"
Tension-type headache responds to OTC analgesics and does not require muscle relaxants, cervical injections, or gabapentinoids. The medication record distinguishes cervicogenic headache from tension headache by treatment intensity.
"The Migraine Is Pre-Existing"
If no triptan or CGRP prescriptions existed before the accident, the pharmacy record proves migraine treatment began post-accident. LienScripts' MERIT report documents this temporal relationship.
Frequently Asked Questions
For lien-based coverage of all headache and migraine medications, LienScripts provides pharmacy services for personal injury patients with no upfront cost.
Related Resources
- Post-Traumatic Migraine and CGRP Treatment: Attorney Guide
- CGRP Medications: A Complete Guide for Personal Injury
- Cyclobenzaprine After Rear-End Collision
- Tizanidine for Neck Spasms After an Accident
- Whiplash Medication Escalation Timeline
Frequently Asked Questions
How can I tell if my client has cervicogenic headache or migraine?
The pharmacy record is diagnostic. Cervicogenic headache is treated with muscle relaxants, NSAIDs, and cervical interventions. Migraine is treated with triptans and CGRP agents. Many post-accident patients have both, documented by medications from both classes.
Can a patient have both cervicogenic headache and migraine after an accident?
Yes, and this is common. Whiplash causes cervicogenic headache from cervical spine damage, while head impact or concussive forces trigger post-traumatic migraine. The dual medication pattern documents two separate injury mechanisms.
Why do defense experts try to reclassify headache types?
Collapsing two distinct headache diagnoses into one reduces the documented injury scope. The pharmacy record prevents this by showing two separate treatment pathways — muscle relaxants for cervicogenic and triptans/CGRP agents for migraine — that cannot be explained by a single diagnosis.